
Astal Laboratories Ltd: Valuation Shift Signals Price Attractiveness Amid Market Challenges
2026-04-15 08:00:14Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift notably, moving from a very expensive to an expensive rating. This change reflects a subtle but significant deterioration in price attractiveness, driven by a combination of elevated price-to-earnings and price-to-book ratios relative to historical and peer benchmarks. Investors face a challenging landscape as the stock underperforms broader indices and peers, prompting a reassessment of its investment appeal.
Read full news article
Astal Laboratories Ltd is Rated Sell
2026-04-13 10:10:14Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article
Astal Laboratories Ltd is Rated Sell
2026-04-02 10:10:16Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news article
Markets Rally, But Astal Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-30 14:55:34Despite a broader market rally, Astal Laboratories Ltd has plunged to a fresh 52-week low of Rs 66 on 30 Mar 2026, marking a notable divergence from the general market trend.
Read full news article
Markets Rally, But Astal Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-24 11:11:46Despite a broader market rally, Astal Laboratories Ltd has plunged to a fresh 52-week low of Rs 68.36 on 24 Mar 2026, marking a sharp divergence from the Sensex’s modest gains. The stock’s recent volatility and sustained downward momentum raise questions about the underlying factors driving this sell-off.
Read full news article
Astal Laboratories Ltd Falls to 52-Week Low of Rs 69.01 as Sell-Off Deepens
2026-03-23 11:42:40A sharp decline in Astal Laboratories Ltd shares has pushed the stock to a fresh 52-week low of Rs 69.01 on 23 Mar 2026, marking a significant 33% drop from its 52-week high of Rs 103.20. This downturn comes amid broader market weakness, but the stock’s underperformance relative to its sector and benchmark indices highlights company-specific pressures.
Read full news article
Astal Laboratories Ltd is Rated Sell
2026-03-22 10:10:13Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Astal Laboratories Ltd Falls to 52-Week Low of Rs.69.84 Amid Market Downturn
2026-03-19 13:35:05Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, touched a fresh 52-week low of Rs.69.84 today, marking a significant decline amid broader market weakness and sectoral underperformance. The stock’s recent price action reflects ongoing pressures despite some positive financial metrics reported over the past year.
Read full news article
Astal Laboratories Ltd Falls to 52-Week Low of Rs.70 Amidst Market Headwinds
2026-03-16 15:41:17Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has touched a new 52-week low of Rs.70 today, marking a significant price level for the stock amid a mixed market environment.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2026 | Source : BSESubmission of certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.
Closure of Trading Window
31-Mar-2026 | Source : BSESubmission of Intimation of closure of trading window.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
20-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aceso Research Labs LLP
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






